A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

CompletedOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

January 23, 2025

Study Completion Date

January 23, 2025

Conditions
Biliary Cirrhosis, Primary
Trial Locations (39)

10016

NYU Langone Health, New York

10021

Weill Cornell Medical College, New York

10032

Columbia University Medical Center, New York

11030

Sandra Atlas Bass Center for Liver Diseases, Manhasset

19104

University of Pennsylvania, Philadelphia

21202

Mercy Medical Center, GI Research, Baltimore

23226

Bon Secours Liver Institute of Virginia, Richmond

23298

Virginia Commonwealth University (VCU), Richmond

27599

University of North Carolina at Chapel Hill, Chapel Hill

27710

Duke University Medical Center, Durham

28204

Center for Liver Disease and Transplant at CMC, Charlotte

30309

Piedmont Atlanta Hospital, Atlanta

32610

University of Florida Hepatology Research, Gainesville

33136

SCFLD/University of Miami, Miami

33762

Gastro Florida, Clearwater

39216

Southern Therapy and Advanced Research LLC (STAR), Jackson

43210

Ohio State University Medical Center, Columbus

48109

University of Michigan, Ann Arbor

52242

University of Iowa, Iowa City

53705

University of Wisconsin, Madison

60005

Illinois Gastroenterology Group, Arlington Heights

60612

Rush University Medical Center, Chicago

60637

University of Chicago, Chicago

63104

Saint Louis University, St Louis

68106

University of Nebraska, Omaha

72204

University of Arkansas, Little Rock

75390

UT Southwestern Medical Center, Dallas

77030

Liver Associates of Texas, P.A., Houston

78233

Pinnacle Clinical Research, Live Oak

80045

University of Colorado- Anschutz Medical Campus, Aurora

85006

Banner University Medical Center, Phoenix

85054

Mayo Clinic, Phoenix

85224

Institute for Liver Health, Chandler

91105

California Liver Research Institute, Pasadena

94304

Stanford University Medical Center, Palo Alto

95817

University of California Davis, Sacramento

98104

University of Washington, Seattle

06520

Yale Internal Medicine, Digestive Diseases, New Haven

Unknown

Baylor,Scott and White All Saints, Fort Worth

All Listed Sponsors
lead

Target PharmaSolutions, Inc.

INDUSTRY

NCT02932449 - A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis | Biotech Hunter | Biotech Hunter